RK

Rajaram Kannan

Active Director Director DIN 01665523
DIN 01665523 First appointment Aug 2007 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2007
Shareholding value •••• Premium profile

About Rajaram Kannan

Data last updated:

Rajaram Kannan is a Director at Cluster Pharma India Private Limited (since 2007). The company operates in Healthcare. Cluster Pharma India Private Limited reported revenue of ₹1.98 Cr (FY 2025).

DIN 01665523
Primary Designation Director
Industry Healthcare
First Appointment 16 Aug 2007
Oldest Company Age 19 yrs
Largest company Cluster Pharma India Private Limited · ₹1.98 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cluster Pharma India Private Limited U24232TZ2007PTC013880
Director16 Aug 20072007₹1.98 Cr (FY 2025)Active

Board colleagues of Rajaram Kannan

NameDINCompanyDesignation
Ramalingam Ravindran01584408Cluster Pharma India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cluster Pharma India Private Limited
Premium access

Shareholding and investment profile for Rajaram Kannan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajaram Kannan

Rajaram Kannan currently holds 1 directorship: Cluster Pharma India Private Limited (Director, since 16 Aug 2007, revenue ₹1.98 Cr (FY 2025)).

Rajaram Kannan was first appointed on 16 Aug 2007 as Director at Cluster Pharma India Private Limited.

The current boards of Rajaram Kannan's companies include Ramalingam Ravindran (Cluster Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available